South Korean real-world treatment patterns in patients with EGFRm NSCLC

被引：0
|
作者：
Lee, J. C. [1 ]
Kim, Y-C. [2 ]
Lee, S. Y. [3 ]
Yoo, S. S. [4 ]
Davis, K. [5 ]
Nagar, S. P. [5 ]
Sawyer, W. [6 ]
Yu, N. [7 ]
Taylor, A. [7 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Chonnam Natl Univ, Sch Med, Hwasun Hosp, Lung Canc Clin,Pulm Med, Jeonnam, South Korea
[3] Korea Univ, Guro Hosp, Pulmonol Allergy & Crit Care Med, Seoul, South Korea
[4] Kyungpook Natl Univ, Chilgok Hosp, Lung Canc Ctr, Daegu, South Korea
[5] RTI Hlth Solut, Hlth Econ Grp, Durham, NC USA
[6] AstraZeneca, Biometr Oncol, Cambridge, England
[7] AstraZeneca, Oncol Business Unit, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
413P
引用
收藏
页码：S1403 / S1403
页数：1
相关论文
共 50 条
  • [1] Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Galdermans, D.
    Pieters, T.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S871 - S872
  • [2] Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Pauwels, P.
    Galdermans, D.
    Pieters, T.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1117 - S1117
  • [3] CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients
    Hernandez, Maurenis
    Ortiz, Ramon A.
    Neninger, Elia
    Amador, Rosa M.
    Cala, Mireisy
    Camacho, Kirenia
    Salomon, Eva
    Guerra, Pedro P.
    Mendoza, Ivis
    Sanchez, Carlos
    Viada, Carmen
    Gonzalez, Matilde
    Torres, Lourdes T.
    Fonseca, Vivian
    Garcia, Lvon
    Bello, Loisel
    Alonso, Maribel
    Rodriguez, Maria C.
    Cruz, Aivin
    Valdes, Rolando
    Lorenzo, Geidy
    Cepeda, Meylan
    Saumel, Yaimarelis
    Crombet, Tania
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S242 - S242
  • [4] Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study
    Greystoke, A.
    Nawaz, A.
    Ferguson, S.
    Pabla, M.
    Sanjeevi, P.
    Bar-Ziv, O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S299 - S300
  • [5] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [6] Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients
    Taugner, J.
    Kaesmann, L.
    Eze, C.
    Floersch, B.
    Guggenberger, J.
    Tufman, A.
    Reinmuth, N.
    Duell, T.
    Belka, C.
    Manapov, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S968 - S968
  • [7] Treatment (tx) patterns and outcomes in resectable early-stage EGFR-mutated (EGFRm) NSCLC in South Korea: Subgroup analysis of a global real-world (rw) study
    Ahn, M-J.
    Kang, J. H.
    Kim, S-W.
    Kahangire, D.
    Nagar, S. P.
    Davis, K. L.
    Jimenez, M.
    Seo, M.
    Jung, M.
    Sandelin, M.
    Cho, B. C.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1650 - S1651
  • [8] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [9] Real-world adjuvant treatment patterns and survival outcomes among early NSCLC US patients
    Lee, J. M.
    Wang, R.
    Johnson, A.
    Ogale, S.
    Kent, M.
    Lee, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S933 - S934
  • [10] Real-world analysis of treatment patterns and efficacy of durvalumab maintenance after chemoradiotherapy in NSCLC patients
    Taugner, J.
    Kaesmann, L.
    Eze, C.
    Ruehle, A.
    Tufman, A.
    Reinmuth, N.
    Duell, T. H-G-F.
    Belka, C.
    Manapov, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S742 - S742
12345